WILMINGTON, Del., Sept. 19, 2013 /PRNewswire/ -- Speaking at the Credit Suisse Chemical & Agriculture Science Conference, DuPont Chair and Chief Executive Officer Ellen Kullman reviewed the company's progress against its strategy to build a higher growth, higher value company.
"Our strategy is clear and is working. We have created and are strengthening world leading positions in three attractive spaces – agriculture and nutrition, bio-based industrials and advanced materials," said Kullman. "We have made good progress and remain focused on continuing to execute successfully against our strategy."
Since 2008, excluding Pharmaceutical royalties, DuPont operating margins increased from about 11 to 18 percent and net income more than doubled reflecting the combined impact of more new products, stronger market positions, an enhanced portfolio and a lower cost structure. During the same period, DuPont returned more capital to its shareholders in the form of dividends and share repurchase as a percentage of its market value than the average of the S&P 500.
Kullman explained how science is an engine for DuPont business growth. "DuPont has one of the broadest, deepest portfolios of scientific knowledge and capability of any enterprise," said Kullman. "We integrate and deploy our science to meet today's customer needs and have a strong and balanced pipeline of new products that will drive our growth in the future."
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.